Risk factors for recurrent rejection in pediatric heart transplantation: A multicenter experience

Journal of Heart and Lung Transplantation

Volumn 23, Issue 2, 2004, Pages 178-185

  Chin, Clifford ^a,f   Naftel, David C ^b   Singh, Tajinder P ^c   Blume, Elizabeth D ^d   Luikart, Helen ^a   Bernstein, Daniel ^a   Gamberg, Pat ^a   Kirklin, James K ^b   Morrow, W Robert ^e  

^a STANFORD UNIVERSITY   (United States)

^b Kentucky   (United States)

^c CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^f Division of Pediatric Cardiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT REJECTION; ADOLESCENT; ARTICLE; CARDIOVASCULAR PERFORMANCE; CHILD; CHRONOSEQUENCE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; HEART TRANSPLANTATION; HUMAN; INFORMATION RETRIEVAL; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; SURGICAL MORTALITY;

EID: 0842286458     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(03)00059-7     Document Type: Article

References (12)

1. Frazier E.A., Naftel D.C., Canter C.E., et al. Death after heart transplantation in children who dies when and why . J Heart Lung Transplant. 18:1999;69.
2. Kobashigawa J.A., Bourge R.C., Naftel D.C., et al. Pre-transplant risk factors for acute rejection after cardiac transplantation a multi-institutional study . J Heart Lung Transplant. 12:1993;355-366.
3. Shaddy R.E., Naftel D.C., Kirklin J.K., et al. Outcome of cardiac transplantation in children survival in a contemporary multi-institutional experience . Circulation. 94:(supplii):1996;69-73.
4. Boucek R.J., Naftel D.C., Boucek M.M., et al. Induction immunotherapy in pediatric heart transplant recipients a multicenter study . J Heart Lung Transplant. 18:1999;460-469.
5. Ventura H.O., Kirklin J.K., Eisen H., Michler R., Clemson B. The combined impact of pretransplant risk factors and rejection frequency and severity on the prevalence of post transplant coronary vasculopathy. [abstract] J Heart Lung Transplant. 16:1997;66.
6. Boucek M.M., Mathis C.M., Boucek R.J., et al. Prospective evaluation of echocardiography for primary rejection surveillance after infant heart transplantation comparison with endomyocardial biopsy . J Heart Lung Transplant. 13:1994;66-73.
7. Webber S.A., Naftel D.C., Parker J., et al. Late rejection episodes greater than 1 year after pediatric heart transplantation risk factors and outcomes . J Heart Lung Transplant. 2004;. (in press).
8. Mills R.M., Naftel D.C., Kirklin J.K., et al. Heart transplant rejection with hemodynamic compromise a multi-institutional study of the role of endomyocardial cellular infiltrate . J Heart Lung Transplant. 16:1997;813-821.
9. Jarcho J., Naftel D.C., Shroyer T.W., et al. Influence of HLA mismatch on rejection after heart transplantation a multi-institutional study . J Heart Lung Transplant. 13:1994;583-596.
10. Kubo S.H., Naftel D.C., Mills R.M., et al. Risk factors for late recurrent rejection after heart transplantation a multiinstitutional, multivariable analysis . J Heart Lung Transplant. 14:1995;409-418.
11. Grice W.N., Konishi T., Apstein C.S. Resistance of neonatal myocardium to injury during normothermic and hypothermic ischemic arrest and reperfusion. Circulation. 76:1987;150-155.
12. Chin C., Akhtar M.J., Rosenthal D.N., Bernstein D. Safety and utility of the routine surveillance biopsy in pediatric patients 2 years after heart transplantation. J Pediatr. 136:2000;238-242.